Sphere Medical develops highly innovative monitoring products to provide clinical and economic benefits in the critical care environment. The products, all of which are based on the company’s proprietary technology, allow minimally invasive, real time measurement of clinical chemistry parameters and therapeutic drug concentrations, giving healthcare professionals the information they require to more effectively manage therapy and optimise patient outcomes.

Sphere Medical was founded in 2002 and is based in Cambridge, UK. Our focus is on the continuous improvement of critical care. Our vision is to lead the way in the provision of products that empower medical institutions with tomorrow’s technology today. Our purpose is to deliver real value to all of our stakeholders.

Three major funding rounds raising over $30 million have enabled Sphere to grow and develop into one of the worlds leading medical device / diagnostic companies, winning a variety of awards including Frost & Sullivan’s Technology Innovation Award in the Field of Point-of-Care Technologies. Sphere is now working with world leading companies in a range of clinical areas to develop the next generation of critical care products incorporating Sphere’s unique micro-analyser platform.